Predicate |
Object |
assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_8150abc57b953408e1bbd20321a2a11b |
classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-70 |
filingDate |
2015-11-10^^<http://www.w3.org/2001/XMLSchema#date> |
inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_068667f009c7d901a3544102b54e2fd3 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_f03cb8538cac8c104b14a27b0708810a http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_fb096e57d0cfd414362b5f3e5e4e5dd0 |
publicationDate |
2015-11-26^^<http://www.w3.org/2001/XMLSchema#date> |
publicationNumber |
AU-2015255202-A1 |
titleOfInvention |
Novel nucleic acid prodrugs and methods of use thereof |
abstract |
[00745] Described herein are nucleic acid prodrugs and nucleic acid prodrugs comprising chiral phosphorous moieties. Also described herein are methods of making and using nucleic acid prodrugs and nucleic acid prodrugs comprising chiral phosphorous moieties. |
priorityDate |
2009-07-06^^<http://www.w3.org/2001/XMLSchema#date> |
type |
http://data.epo.org/linked-data/def/patent/Publication |